Georgetown University
Clinical trials sponsored by Georgetown University, explained in plain language.
Upcoming readouts
Trials from this sponsor expected to report results within the next 12 months.
- Can an online sleep program help black prostate cancer survivors get better rest? Results expected Sep 2026 (estimated)
- New hope for AML patients: maintenance chemo combo aims to keep remission going Results expected Dec 2026 (estimated)
- New drug combo shows promise for Hard-to-Treat CLL Results expected Dec 2026 (estimated)
- Could a pill shield hearts from chemo damage? new study investigates Results expected Dec 2026 (estimated)
- Can a Self-Compassion class ease anxiety and depression? new study tests In-Person vs. online Results expected Dec 2026 (estimated)
-
Experimental drug K0706 tested for lewy body dementia
Symptom relief Stopped earlyThis study looked at whether a drug called K0706 is safe and tolerable for people with Dementia with Lewy Bodies (DLB). Researchers planned to give 45 participants either a low dose, high dose, or placebo for 12 weeks, then check for side effects and measure changes in brain and …
Phase 2 • Sponsor: Georgetown University • Aim: Symptom relief
Last updated Jun 27, 2026 13:05 UTC
-
Cancer drug tested before surgery for non-invasive breast condition
Knowledge-focused Stopped earlyThis study looked at whether giving the drug palbociclib before surgery could cause changes in breast tissue in people with ductal carcinoma in situ (DCIS), a very early form of breast cancer. It planned to enroll 24 participants, but was stopped early after only 17 joined. The m…
Phase 2 • Sponsor: Georgetown University • Aim: Knowledge-focused
Last updated Jun 27, 2026 07:51 UTC